Tenet Healthcare Corp (NYSE:THC) expected to announces of its Q1 earnings on Tuesday, April 30, 2013. As the analysts have become more wary as anticipations have dropped in excess of the previous month to earnings of 28 cents a share from earnings of 36 cents a share.
Current Wall Street anticipates reflect a 46.2 percent drop from the year-before quarter, at what time the firm declared earnings of 52 cents a share.
The consensus predicts has plunged over the previous quarter from 62 cents. The analysts are predicting earnings of $2.74 a share for the fiscal year. Revenue is predicted to be $2.48B for the quarter, 5.5 percent higher than the year-earlier total of $2.35B. The revenue is predated to roll in at $9.98B for the year.
Tenet Healthcare Corp (NYSE:THC) stock hit highest price at $41.53, beginning with a price of $39.93 and reported increased +3.24% to the closed at $41.16 with day range of $39.93-$41.53. The total market capitalization remained $4.32 billion, total volume held in the session was 2.08 million shares surprisingly higher than its average volume of 2.07 million shares.
To check the Stocks ups and downs, THC last week stock price volatility remained 2.72% and month was at 3.53%. THC generated revenue of 9.12 billion in the following twelve months income of $217.00 million. The Company showed a positive 2.29% in the net profit margin and in addition to in its operating margin which remained 8.17%. Company’s annual sales growth for the past five year was 2.44%.
The THC past twelve months price to sales ratio was 0.47 and price to cash ratio remained 11.78. As far as if notice on other major contributors of similar sectors have sale ratio and price to cash ratio remained Health Management Associates Inc (NYSE:HMA)’s P/S 0.49% P/C 16.09%, Universal Health Services, Inc. (NYSE:UHS)’s P/S 0.91% P/C 270.52%, Community Health Systems (NYSE:CYH)’s P/S 0.31% P/C 10.54%, Select Medical Holdings Corporation (NYSE:SEM)’s P/S 0.40% P/C 29.56%.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here